Previously, we have screened growth inhibition activities of arylsulfonamide compounds designed as Stat3 inhibitors against pancreatic cancer cell lines12, as Stat3 activation is important for cancer progression3. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.